New Developments in Life Science Technology
Hi there, This month, I am pleased to shine a light on the work of Discovery to Impact, and particularly my dear friend and colleague, Mike Yost, Ph.D., Director of Life Science Technology Development. While there are more than 130 programs at the University of Texas devoted to championing entrepreneurship and intellectual property creation, Discovery to Impact is at the center of this vibrant ecosystem. This team oversees the university’s technology transfer and corporate-sponsored research functions and two startup incubators while building relationships with campus creators and inventors as well as corporations, investors and entrepreneurs to get research out of the labs and studios and into the world where it can be put to the greatest use. In the video above, Mike shares two exciting development currently underway at Discovery to Impact. The UT Life Science Technology Development unit accelerates the translation of groundbreaking discoveries into real-world solutions. This is the type of life-changing technology we are constantly in pursuit of at i4Health. By highlighting their work, it is my hope we can continue to invest and support innovative solutions and build interdisciplinary partnerships that make a tangible impact on patients’ lives and the future of health care. For now, I invite you to explore more news and resources below, and to continue the constant pursuit of the innovation mindset!
– Janet C. Walkow, Ph.D. |
|
Janet Walkow Named 2025 Change Maker
My goal is to inspire novel approaches and solutions that promote development of health technologies, facilitate bioscience startups and cultivate interdisciplinary technology and workforce readiness. Learn how I harness time in the classroom to help others develop innovative careers solving the world’s largest health problems, via Austin Woman. |
|
Health Innovations in the News |
FDA Clears Antibiotic for Superbug Infections
AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative bacteria that represent a serious threat to public health. |
SXSW Innovation Awards Finalists Announced
The 55 finalists provide a glimpse of the future in 11 different categories ranging from Artificial Intelligence to Health & Biotech to Community Empowerment. Browse categories and links below to learn more about the 2025 SXSW Innovation Awards finalists. |